SNYR — Synergy CHC Share Price
- $14.38m
- $20.57m
- $40.23m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 0.38 | ||
Price to Sales | 0.02 | ||
EV to EBITDA | 1.85 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 1857.67% | ||
Return on Equity | n/a | ||
Operating Margin | 8.05% |
Financial Summary
Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 34.84 | 35.6 | 33.82 | 29.36 | 40.23 | n/a | n/a | 24.49% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | -57.62 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Synergy CHC Corp. is a consumer healthcare and beauty company. The Company is a portfolio of consumer health care and beauty brands, including FOCUS factor, FLAT TUMMY CO, HAND MD, Sneaky Vaunt, THE QUEEN PEGASUS. FOCUS factor is a brain health supplement brand. FLAT TUMMY CO is a lifestyle brand, which helps women achieve their nutrition and weight management goals. HAND MD is a hand care brand to maintain clean, healthy and beautiful hands. THE QUEEN PEGASUS provides eyelash serum for longer and thicker looking natural lashes. Sneaky Vaunt offers flat tummy tea.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- June 30th, 2021
- Incorporated
- December 29th, 2010
- Public Since
- November 8th, 2013
- No. of Employees
- 39
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 89,889,074
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 865 Spring St, WESTBROOK, 04092-3828
- Web
- https://synergychc.com/
- Phone
- +1 6159399004
- Auditors
- RBSM LLP
Upcoming Events for SNYR
Similar to SNYR
Adia Nutrition
Pink Sheets on Nasdaq
Agri-Dynamics
Pink Sheets on Nasdaq
Agristar
Pink Sheets on Nasdaq
Aifarm
Pink Sheets on Nasdaq
AiXin Life International
Pink Sheets on Nasdaq
FAQ
As of Today at 23:35 UTC, shares in Synergy CHC are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Synergy CHC last closed at $0.01 and the price had moved by -60% over the past 365 days. In terms of relative price strength the Synergy CHC share price has underperformed the S&P500 Index by -66.43% over the past year.
There is no consensus recommendation for this security.
Synergy CHC does not currently pay a dividend.
Synergy CHC does not currently pay a dividend.
Synergy CHC does not currently pay a dividend.
To buy shares in Synergy CHC you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Synergy CHC had a market capitalisation of $0.90m.
Here are the trading details for Synergy CHC:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SNYR
Based on an overall assessment of its quality, value and momentum Synergy CHC is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Synergy CHC. Over the past six months, its share price has underperformed the S&P500 Index by -9.44%.
As of the last closing price of $0.01, shares in Synergy CHC were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Synergy CHC PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Synergy CHC's management team is headed by:
- Jack Ross - CHM
- Stephen Fryer - DRC
- Paul SoRelle - DRC
- Gale Bensussen - IND